Kopasker, D. , Robertson, C., Aucott, L., Vadiveloo, T., Imamura, M., Manson, P., Walker, A., Urquhart, G., Brazelli, M. and Scotland, G. (2021) Enzalutamide with ADT for treating metastatic hormone-sensitive prostate cancer [ID1605]. Other. Aberdeen HTA Group.
Full text not currently available from Enlighten.
Publisher's URL: https://www.nice.org.uk/guidance/ta712/evidence
Abstract
No abstract available.
| Item Type: | Research Reports or Papers (Other) |
|---|---|
| Additional Information: | NICE Single Technology Appraisal. |
| Status: | Published |
| Glasgow Author(s) Enlighten ID: | Kopasker, Dr Daniel |
| Authors: | Kopasker, D., Robertson, C., Aucott, L., Vadiveloo, T., Imamura, M., Manson, P., Walker, A., Urquhart, G., Brazelli, M., and Scotland, G. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Health & Wellbeing > MRC/CSO SPHSU |
| Publisher: | Aberdeen HTA Group |
| Published Online: | 07 July 2021 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details